| pubmed-article:18332481 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18332481 | lifeskim:mentions | umls-concept:C0039796 | lld:lifeskim |
| pubmed-article:18332481 | lifeskim:mentions | umls-concept:C0079189 | lld:lifeskim |
| pubmed-article:18332481 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:18332481 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:18332481 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:18332481 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:18332481 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18332481 | pubmed:dateCreated | 2008-3-11 | lld:pubmed |
| pubmed-article:18332481 | pubmed:abstractText | The Ras family of small guanosine triphosphatases normally transmit signals from cell surface receptors to the interior of the cell. Stimulation of cell surface receptors leads to the activation of guanine exchange factors, which, in turn, convert Ras from an inactive GDP-bound state to an active GTP-bound state. However, in one third of human cancers, RAS is mutated and remains in the constitutively active GTP-bound state. In this oncogenic state, RAS activates a constellation of signaling that is known to promote tumorigenesis. One consequence of this oncogenic RAS signal in cancer cells is the upregulation of the cytokines interleukin (IL)-6, IL-8, and chemokine growth-regulated oncogene 1 (GRO-1). We review the evidence supporting a role for these cytokines in oncogenic RAS-driven solid tumors. | lld:pubmed |
| pubmed-article:18332481 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18332481 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18332481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18332481 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18332481 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:18332481 | pubmed:issn | 1534-0384 | lld:pubmed |
| pubmed-article:18332481 | pubmed:author | pubmed-author:CounterChrist... | lld:pubmed |
| pubmed-article:18332481 | pubmed:author | pubmed-author:AncrileBrooke... | lld:pubmed |
| pubmed-article:18332481 | pubmed:author | pubmed-author:O'HayerKevin... | lld:pubmed |
| pubmed-article:18332481 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18332481 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:18332481 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18332481 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18332481 | pubmed:pagination | 22-7 | lld:pubmed |
| pubmed-article:18332481 | pubmed:dateRevised | 2011-2-18 | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:meshHeading | pubmed-meshheading:18332481... | lld:pubmed |
| pubmed-article:18332481 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18332481 | pubmed:articleTitle | Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics. | lld:pubmed |
| pubmed-article:18332481 | pubmed:affiliation | Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA. | lld:pubmed |
| pubmed-article:18332481 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18332481 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18332481 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18332481 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18332481 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18332481 | lld:pubmed |
